|
|
|
Volumn 120, Issue , 2009, Pages 163-173
|
|
Statins and ezetimibe modulate plasma proprotein convertase subtilisin kexin-9 (PCSK9) levels.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATORVASTATIN;
AZETIDINE DERIVATIVE;
EZETIMIBE;
HEPTANOIC ACID DERIVATIVE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
LOW DENSITY LIPOPROTEIN RECEPTOR;
MESSENGER RNA;
PCSK9 PROTEIN, HUMAN;
PYRROLE DERIVATIVE;
SERINE PROTEINASE;
ADULT;
AGED;
ARTICLE;
BLOOD;
CASE CONTROL STUDY;
CELL STRAIN CACO 2;
CELL STRAIN HEPG2;
ENZYMOLOGY;
FEMALE;
GENETIC VARIABILITY;
GENETICS;
HUMAN;
HYPERLIPOPROTEINEMIA TYPE 2;
MALE;
METABOLISM;
MIDDLE AGED;
MUTATION;
ADULT;
AGED;
ANTICHOLESTEREMIC AGENTS;
AZETIDINES;
CACO-2 CELLS;
CASE-CONTROL STUDIES;
FEMALE;
GENETIC VARIATION;
HEP G2 CELLS;
HEPTANOIC ACIDS;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPOPROTEINEMIA TYPE II;
MALE;
MIDDLE AGED;
MUTATION;
PYRROLES;
RECEPTORS, LDL;
RNA, MESSENGER;
SERINE ENDOPEPTIDASES;
YOUNG ADULT;
|
|
EID: 73449109571
PISSN: 00657778
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (75)
|
|
References (0)
|
